Company News

EN

EN
CN

News

Company News

News

Company News

MicroPort EP Obtains ANVISA Approval for FireMagic™ RF Ablation Catheters

MicroPort EP obtained the regulatory approval by Brazil ANVISA for its independently developed FireMagic™ Irrigated Ablation Catheter and FireMagic™ 3D Irrigated Ablation Catheter.

06-20

2022
MicroPort EP Attended Turkish National Arrhythmia Meeting 2022

MicroPort EP recently attended the Annual Congress of the Turkish National Arrhythmia Meeting 2022.

06-05

2022
MicroPort EP Attended HRS 2022

MicroPort EP recently attended the Annual Congress of the European Heart Rhythm Society 2022 (HRS 2022) in San Francisco.

05-12

2022
MicroPort EP Attended EHRA 2022

MicroPort EP recently attended the Annual Congress of the European Heart Rhythm Association 2022 (EHRA 2022) in Copenhagen.

04-11

2022
MicroPort EP Obtains FDA Approval for PathBuilder™ Transseptal Guiding Introducer and Transseptal Needle

MicroPort EP obtained FDA approval in U.S.A for its in-house developed PathBuilder™ Transseptal Guiding Introducer and Transseptal Needle.

03-26

2022
MicroPort EP Obtains TGA Approval for PathBuilder™ Set in Australia

Canberra，Australia——MicroPort EP obtained the regulatory approval by Australia TGA for its independently developed PathBuilder™ Steerable introducer ，PathBuilder™ Transseptal Guiding Introducer and Needle.

02-15

2022

Prev 4 5 6 7 8 9 10 11 12 ... Next

Tel：

(86)(21)60969600

Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China

Legal Statement

Privacy Policy

©Copyright 2023, Shanghai MicroPort EP MedTech Co., Ltd. All rights reserved.

Website License Number：Shanghai ICP Record No.16034362

Internet Drug Information Service Qualification Certificate Number: (Shanghai) - non operational - 2016-0126

            
Home

Tel

Top